These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14981799)

  • 1. [Human recombinant interferon-alpha 2a polybutylcyanoacrylate sustained release lyophilized nanospheres for liver-targeting].
    Lu B; Feng JF; Yang XC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):1-4. PubMed ID: 14981799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22].
    Yang YX; Zhu L; He X; Bao DY; Bao X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):68-70. PubMed ID: 14981819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
    Sun X; Wu F; Lu W; Zhang ZR
    Pharmazie; 2004 Oct; 59(10):791-4. PubMed ID: 15544059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
    Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute toxicity of liver targeting mitoxantrone-nanospheres].
    Zhang Z; Liao G
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):38-40. PubMed ID: 7657335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
    Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles].
    Zhang ZR; Lu W
    Yao Xue Xue Bao; 1997; 32(3):222-7. PubMed ID: 11327027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
    Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
    J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An observation of the anticarcinogenic effect of mitoxantrone-polybutylcyanoacrylate-nanosperes].
    Zhang Z; Liao G; Hou S; Bai S; Zhang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):381-4. PubMed ID: 8150436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on mitoxantrone polycyanoacrylate nanospheres].
    Zhang ZR; Liao GT; Hou SX
    Yao Xue Xue Bao; 1994; 29(7):544-9. PubMed ID: 7976360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on liver targeted valaciclovir polybutylcyanoacrylate nanoparticles].
    Zhang Z; He Q
    Yao Xue Xue Bao; 1998 Sep; 33(9):702-6. PubMed ID: 12016876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.
    Mitra A; Lin S
    J Pharm Pharmacol; 2003 Jul; 55(7):895-902. PubMed ID: 12906746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
    Joshi SA; Chavhan SS; Sawant KK
    Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
    Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of polybutylcyanoacrylate magnetic nanoparticles.
    Ren F; Chen JH; Jiang YD; Chen ZL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):161-3. PubMed ID: 14965816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
    Wadler S; Goldman M; Lyver A; Wiernik PH
    Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles].
    Chen RD; Ren F; Li GF; Liu SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution].
    Zhang XN; Zhang Q; Wen H; Wang GQ; Sun DJ
    Yao Xue Xue Bao; 2003 Jun; 38(6):462-6. PubMed ID: 14513810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.